1. Association of Chlamydia trachomatis Infection With Breast Cancer Risk and the Modification Effect of IL-12.
- Author
-
Li N, Xiao C, Li Y, Zhang Y, Lin Y, Liu Q, Tang L, Xu L, and Ren Z
- Subjects
- Humans, Female, Case-Control Studies, Middle Aged, Adult, Risk Factors, China epidemiology, Immunoglobulin G blood, Immunoglobulin G immunology, Receptors, Estrogen metabolism, Antibodies, Bacterial blood, Antibodies, Bacterial immunology, Breast Neoplasms immunology, Breast Neoplasms blood, Chlamydia trachomatis immunology, Chlamydia trachomatis isolation & purification, Chlamydia Infections complications, Chlamydia Infections immunology, Chlamydia Infections epidemiology, Interleukin-12 blood, Interleukin-12 immunology
- Abstract
Background: Chlamydia trachomatis (C. trachomatis) infection has been implicated in various cancers, yet its association with breast cancer remains unexplored. This infection triggers a cascade of immune responses primarily regulated by Interleukins-12 (IL-12). Thus, the objective of this case-control study was to investigate the link between C. trachomatis infection and breast cancer risk, as well as the modification effect of IL-12., Methods: We assessed IgG levels against C. trachomatis in serum of 1,121 women with breast cancer (861 with estrogen receptor-positive (ER+) and 260 with estrogen receptor-negative (ER-) tumors) and 400 controls in Guangzhou, China. Logistic regression models were applied to estimate the odds ratios (ORs) and 95% confidence intervals (95% CIs) for breast cancer risk in association with C. trachomatis infection. The interaction between C. trachomatis infection and IL-12 on breast cancer risk was estimated by the product terms in the logistic regression models., Results: Seropositivity of C. trachomatis IgG showed a slight association with an increased risk of breast cancer (OR = 1.20; 95% CI: 0.86∼1.78). This association was more pronounced among women with a higher (OR = 5.82; 95% CI: 1.31∼25.94) than a lower (OR = 0.73; 95% CI: 0.41∼1.30) level of IL-12, with a statistically significant interaction observed (P
interaction = 0.013). In addition, C. trachomatis IgG seropositivity was related to an increased risk of breast cancer among PR+ patients (OR = 1.53; 95% CI: 1.04∼2.23)., Conclusions: C. trachomatis infection may contribute to the development of hormone-responsive breast cancer in women with high levels of IL-12. Further studies are needed to uncover the underlying mechanisms., Competing Interests: Disclosure The authors declare that they have no competing interests., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF